Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

CD133+ cells are crucial for hair growth.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

CD4+ skin cells may be precursors to basal cell carcinoma.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

BST2 protein and certain T cells increase in early alopecia areata.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

γδ T cells adapt uniquely to different tissues in mice.

The role of γδT-cells in causing alopecia areata remains unclear.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.